Head and neck squamous cell carcinoma (HNSCC) have an infiltrate containing NK as well as CD8+ T cells expressing NKG2A alone or co-expressing NKG2A and PD1 thus leading to clinical trials targeting both PD-L1 and NKG2A. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.